A schematic illustration of how GigTIME can take a hematoxylin and eosin (H&E) pathology slide and use AI to virtually identify a suite of proteins that would otherwise require multiplex immunofluorescence (mIF). (Microsoft, Providence and UW Illustration) Pacific Northwest tech and cancer researchers are publicly releasing an AI tool that can perform sophisticated tumor analysis in a fraction of the time and cost of existing methods, potentially making cutting-edge cancer insights available to ...